查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1466284

心血管设备市场：按设备类型、适应症和最终用户划分 - 全球预测 2024-2030

Cardiovascular Devices Market by Device Type (Diagnostic & Monitoring Devices, Therapeutic & Surgical Devices), Indication (Cardiac Arrhythmia, Coronary Artery Disease, Heart Failure), End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年心血管器材市场规模为536.9亿美元，预计2024年将达575.5亿美元，2030年将达884亿美元，复合年增长率为7.38%。

心血管设备是用于诊断、治疗和管理与心臟和循环系统相关的疾病的专用设备和工具。这包括广泛的产品，包括心律调节器、支架、心臟瓣膜、监测设备和手术器械。由于人口老化、久坐的生活方式以及高血压、糖尿病和普及等危险因子的普遍存在，全球心血管疾病发病率不断上升，推动了这一趋势的发展。技术创新和研发进步相结合，显着提高了这些设备的有效性和安全性，进一步推动了需求。然而，市场面临严格的监管环境、先进心血管设备的高成本以及需要熟练的专业人员操作先进设备等挑战。另一方面，由于医疗保健成本不断上升、持续心臟健康监测的可穿戴技术的整合、对心血管疾病的认识不断提高以及对微创手术的需求不断增长，新兴市场代表着巨大的成长机会。此外，持续研究带来具有成本效益的创新产品，可能为该领域的扩张开闢新的途径。

主要市场统计
基准年[2023] 536.9亿美元
预测年份 [2024] 575.5亿美元
预测年份 [2030] 884亿美元
复合年增长率（%） 7.38%

设备类型：对于诊断和管理高血压至关重要的血压计的采用正在迅速增加

血压计测量动脉血压，对于高血压的诊断和管理至关重要。心臟 CT 和 MRI 扫描仪是先进的影像工具，可提供心臟结构和功能的详细影像，有助于检测心臟病和病症。心电图 (ECG) 机器记录一段时间内心臟的电活动，以诊断心律和其他心血管问题。动态心电图类似于心电图，是一种携带式设备，可以在 24 小时内追踪心律和电活动，并可以帮助检测标准心电图上可能无法显示的心律不整。远端心臟监测系统可以使用无线技术远距离监测患者的心臟活动，对于患有慢性心臟病的患者特别有用。压力测试系统检查身体压力下的心臟功能，通常是在跑步机或固定自行车上进行。您可以发现休息时不易察觉的心臟疾病。人造心臟是一种植入以替代衰竭心臟的装置，通常是暂时的，直到可以进行心臟移植为止。心肌消融导管用于心肌消融术，透过疤痕或破坏导致心律异常的心臟组织来治疗心律异常。冠状动脉导管导引线是细而柔韧的导线，可用于在打开心臟阻塞动脉的手术过程中引导支架和球囊等装置的放置。心臟监视器类似心电图监测，记录心臟活动，可以长时间使用。它通常用于手术后或诊断长期心臟病。机械和生物心臟瓣膜用于取代患病的心臟瓣膜，在瓣膜性心臟病的治疗中发挥重要作用。植入式心臟整流去颤器(ICD) 会监测心律，并在必要时进行电击，使其恢復正常心律。用于有心臟猝死风险的患者。心律调节器植入胸部以控制异常心律，并使用电脉衝促进心臟正常跳动。支架是插入狭窄或阻塞动脉的小管，以保持动脉畅通并改善流向心臟的血液。辅助人工心臟(VAD) 是一种机械泵，可为心臟衰弱的人提供心臟功能和血流支持。

最终用户：扩大心血管设备在门诊手术中心的使用

门诊手术中心是提供手术和某些不需要住院治疗的医疗程序的医疗机构。由于其成本效益和效率，ASC 越来越多地被用作小型心臟相关手术的心血管设备。这些中心拥有用于门诊心臟手术的设备，包括诊断测试和小型手术。 ASC 的一个关键优势是能够提供高品质、及时的患者照护并减少住院需求。医院配备了各种等级的心臟护理设备，从基本的诊断设备到先进的手术设备。医院对于急性心臟疾病的管理、危重手术的实施以及提供包括诊断、治疗和復健在内的综合护理至关重要。该医院广泛的基础设施和多学科团队对于解决复杂的心血管病例至关重要，并在心血管设备市场中发挥关键作用。专科诊所专注方面医疗保健的特定方面，有些专科诊所仅专注于心臟病学和循环系统健康。这些诊所主要利用心血管设备进行诊断、持续患者监测和小型治疗程序。专科诊所以提供有针对性的个人化护理而闻名，并且通常根据心臟病患者的特定需求提供量身定制的服务。我们的重点是慢性心血管疾病管理、预防策略和病患教育，当需要更先进的治疗时，我们经常与医院合作。

区域洞察

在美洲，高额医疗保健支出、先进的医疗保健系统以及主要设备製造商的存在正在推动市场成长。该地区的法规结构非常严格，食品药物管理局(FDA)监督设备核准，以确保安全性和有效性。由于医疗设施的改善、可支配收入的增加以及心血管疾病负担的增加，亚太地区（APAC）心血管器材市场正在迅速扩张。该地区的特点是监管环境多样化，各国处于不同的监管发展阶段，企业必须谨慎应对。儘管如此，随着政府增加对医疗基础设施和保险系统的投资以使医疗保健更容易获得，中国和印度等快速增长的经济体为医疗设备製造商提供了巨大的商机。在 EMEA（欧洲、中东和非洲）地区，由于人口老化、医疗保健标准提高以及政府积极努力管理心血管疾病，对心血管设备的需求不断增加。在该地区运营的公司受益于欧洲国家先进的医疗保健系统以及中东和非洲的新兴市场潜力，以及支持市场进入和扩张的不断发展的法律规范。

FPNV定位矩阵

FPNV定位矩阵对于评估心血管器材市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对心血管设备市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，以获得市场竞争优势。

本报告在以下方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4. 竞争评估和情报：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1.心血管器材市场规模及预测是多少？

2.在心血管器材市场的预测期内，有哪些产品、细分市场、应用和领域需要考虑投资？

3.心血管器材市场的技术趋势和法规结构是什么？

4.心血管器材市场主要厂商的市场占有率是多少？

5.进入心血管器材市场合适的型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 心血管疾病负担增加
      • 人们对微创手术的兴趣日益浓厚
      • 改善新兴国家的医疗设施并扩大医疗服务范围
    • 抑制因素
      • 严格的监管政策和产品召回
    • 机会
      • 整合穿戴技术持续监测心臟健康
      • 持续研究心血管设备的生物相容性与材料科学
    • 任务
      • 退款政策数量有限
  • 市场区隔分析
    • 设备类型：血压计的快速普及，对于高血压的诊断和管理至关重要
    • 最终使用者：门诊手术中心心血管设备使用的演变
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章依设备类型分類的心血管设备市场

  • 诊断和监测设备
  • 治疗及手术设备

第七章依适应症分類的心血管器材市场

  • 心律不整
  • 冠状动脉疾病
  • 心臟衰竭
  • 周边动脉疾病

第八章心血管设备市场：依最终用户分类

  • 门诊手术中心
  • 医院
  • 专科诊所

第九章美洲心血管器械市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太心血管器材市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲的心血管器材市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争场景分析
    • 强生以 131 亿美元收购 Shockwave Medical，以加强心血管护理服务
    • Medtronic)和心臟设计实验室 (Cardiac Design Labs) 在印度推出创新的外部循环记录器技术
    • InfoBionic 的 MoMe ARC 获得 FDA核准，堪称心臟监测领域的一场革命
  • 战略分析和建议

第13章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-D2073C5D8E6E

[183 Pages Report] The Cardiovascular Devices Market size was estimated at USD 53.69 billion in 2023 and expected to reach USD 57.55 billion in 2024, at a CAGR 7.38% to reach USD 88.40 billion by 2030.

Cardiovascular devices are specialized equipment and tools deployed in diagnosing, treating, and managing diseases related to the heart and the overall cardiovascular system. This range encompasses a broad spectrum of products, including pacemakers, stents, heart valves, monitoring devices, and surgical instruments. The rising incidences of cardiovascular diseases globally, driven by an aging population, sedentary lifestyles, and the prevalence of risk factors including hypertension, diabetes, and obesity, drive the adoption. Innovations in technology, coupled with advancements in research and development, have significantly improved the efficacy and safety of these devices, further propelling their demand. However, the market faces challenges, including stringent regulatory landscapes, high costs associated with advanced cardiovascular devices, and the need for skilled professionals to operate sophisticated equipment. On the other hand, emerging markets represent a significant opportunity for growth, given the increasing healthcare expenditure, wearable technology integration for continuous heart health monitoring, growing awareness about cardiovascular diseases, and the rising demand for minimally invasive procedures. Moreover, continuous research leading to innovative products that offer cost-effective outcomes can open new avenues for expansion in this sector.

KEY MARKET STATISTICS
Base Year [2023] USD 53.69 billion
Estimated Year [2024] USD 57.55 billion
Forecast Year [2030] USD 88.40 billion
CAGR (%) 7.38%

Device Type: Burgeoning adoption of blood pressure monitors essential for diagnosing and managing hypertension

Blood pressure monitors measure the pressure of blood in the arteries, which is essential for diagnosing and managing hypertension. Cardiac CT & MRI scanners are advanced imaging tools that provide detailed pictures of the heart's structure and function, helping detect heart diseases and conditions. Electrocardiogram devices (ECG devices) record the heart's electrical activity over a period for diagnosing heart rhythms and other cardiovascular problems. Holter monitors are similar to ECGs; these portable devices track the heart's rhythm and electrical activity for 24 hours or more, helping detect irregularities that might not appear during a standard ECG exam. Remote cardiac monitoring systems allow for monitoring a patient's heart activity from a distance using wireless technology, which is especially useful for patients with chronic heart conditions. Stress test systems examine the heart's performance under physical stress, usually on a treadmill or stationary bike. They can detect heart diseases that are not noticeable at rest. Artificial hearts are devices implanted to replace the failing heart, usually used temporarily until a heart transplant can be performed. Cardiac ablation catheters are used in a procedure known as cardiac ablation, and they treat abnormal heart rhythms by scarring or destroying tissue in the heart that triggers abnormal heart rhythm. Coronary guidewires are thin, flexible wires that are useful in guiding the placement of devices such as stents or balloons during procedures to open up blocked arteries in the heart. Heart monitors are similar to Holter monitors; these devices keep track of the heart's activity and can be used for extended periods. They are often used after surgery or to diagnose long-term heart conditions. Heart valves can be mechanical or biological used to replace diseased heart valves and are critical in managing heart valve disorders. Implantable cardioverter defibrillators (ICDs) monitor heart rhythms and deliver electric shocks to restore a normal rhythm if necessary. They're used in patients at risk of sudden cardiac death. Pacemakers are implanted in the chest to control abnormal heart rhythms and use electrical pulses to prompt the heart to beat normally. Stents are tiny tubes inserted into narrow or blocked arteries to keep them open, improving blood flow to the heart. Ventricular assist devices (VADs) are mechanical pumps that support heart function and blood flow in individuals with weakened hearts.

End-User: Evolving utilization of cardiovascular devices across the ambulatory surgical centers

Ambulatory surgical centers are healthcare facilities that deliver surgery and specific medical procedures that do not require hospital admission. Due to their cost-effectiveness and efficiency, ASCs are increasingly utilized as cardiovascular devices for minor heart-related procedures. These centers have devices for outpatient cardiac procedures, including diagnostic tests and minor surgical interventions. The critical advantage of ASCs is their ability to offer high-quality, timely patient care, reducing the need for hospital stays. Hospitals are equipped with an expansive range of devices, from essential diagnostic tools to advanced surgical equipment, catering to all levels of cardiac care. Hospitals are central to managing acute cardiac conditions, performing significant surgeries, and providing comprehensive care, including diagnosis, treatment, and rehabilitation. The extensive infrastructure and multidisciplinary teams in hospitals are essential for handling complex cardiovascular cases, making them critical players in the cardiovascular device market. Specialty clinics focus on specific aspects of healthcare, with certain clinics dedicated entirely to cardiology and cardiovascular health. These clinics utilize cardiovascular devices primarily for diagnostic purposes, ongoing patient monitoring, and minor treatment procedures. Specialty clinics are known for providing targeted and personalized care, often offering services tailored to the specific needs of patients with heart diseases. They significantly manage chronic cardiovascular conditions, prevention strategies, and patient education, frequently collaborating with hospitals for more advanced care needs.

Regional Insights

In the Americas, the market growth is driven by high healthcare expenditure, sophisticated healthcare systems, and a strong presence of major device manufacturers. The regulatory framework in this region is stringent, with the food and drug administration (FDA) overseeing device approval to ensure safety and efficacy. In the Asia-Pacific (APAC) region, the market for cardiovascular devices is expanding rapidly due to improving healthcare facilities, increasing disposable incomes, and a growing burden of cardiovascular diseases. The region is marked by a diverse regulatory landscape with countries at different stages of regulatory growth, which companies must navigate carefully. Nonetheless, fast-growing economies such as China and India provide significant opportunities for device manufacturers, as governments increasingly invest in health infrastructure and insurance schemes to make healthcare more accessible. The EMEA region showcases a demand for cardiovascular devices driven by an aging population, rising healthcare standards, and favorable government initiatives aimed at cardiovascular disease management. Companies operating in this region benefit from the advanced healthcare systems in European countries and emerging market potential in the Middle East and Africa, guided by the evolving regulatory frameworks to support market entry and expansion.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cardiovascular Devices Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cardiovascular Devices Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cardiovascular Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACS Diagnostics, Alivecor, Inc., Asahi Kasei Corporation, B. Braun SE, Baxter International Inc., Bexen Medical, Biotronik SE & Co KG, Boston Scientific Corporation, BPL Medical Technologies Private Limited, GE Healthcare, HeartFlow Holding, Inc., Johnson & Johnson Services, Inc., Koninklijke Philips N.V.,, Lepu Medical Technology(Beijing)Co., Ltd., LivaNova PLC, Medtronic PLC, Microport Scientific Corporation, Nihon Kohden Corporation, Qardio, Inc., Schiller AG, Terumo Medical Corporation, Tricog Health, Vesalius Cardiovascular Inc., and Zoll Medical Corporation.

Market Segmentation & Coverage

This research report categorizes the Cardiovascular Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Device Type
    • Diagnostic & Monitoring Devices
      • Blood Pressure Monitors
      • Cardiac CT & MRI Scanners
      • Electrocardiogram Devices
      • Holter Monitors
      • Remote Cardiac Monitoring
      • Stress Test Systems
    • Therapeutic & Surgical Devices
      • Artificial Hearts
      • Cardiac Ablation Catheters
      • Coronary Guidewires
      • Heart Monitors
      • Heart Valves
      • Implantable Cardioverter Defibrillators
      • Pacemakers
      • Stents
      • Ventricular Assist Devices
  • Indication
    • Cardiac Arrhythmia
    • Coronary Artery Disease
    • Heart Failure
    • Peripheral Arterial Disease
  • End-User
    • Ambulatory Surgical Centers
    • Hospitals
    • Specialty Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Cardiovascular Devices Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cardiovascular Devices Market?

3. What are the technology trends and regulatory frameworks in the Cardiovascular Devices Market?

4. What is the market share of the leading vendors in the Cardiovascular Devices Market?

5. Which modes and strategic moves are suitable for entering the Cardiovascular Devices Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing burden of cardiovascular diseases
      • 5.1.1.2. Rising preference for minimally invasive procedures
      • 5.1.1.3. Improved healthcare facilities and the expanding reach of healthcare services in emerging economies
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent regulatory policies and product recalls
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of wearable technology for continuous monitoring of heart health
      • 5.1.3.2. Ongoing research in the biocompatibility and material science of cardiovascular device
    • 5.1.4. Challenges
      • 5.1.4.1. Limited number of reimbursement policies
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Device Type: Burgeoning adoption of blood pressure monitors essential for diagnosing and managing hypertension
    • 5.2.2. End-User: Evolving utilization of cardiovascular devices across the ambulatory surgical centers
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Cardiovascular Devices Market, by Device Type

  • 6.1. Introduction
  • 6.2. Diagnostic & Monitoring Devices
  • 6.3. Therapeutic & Surgical Devices

7. Cardiovascular Devices Market, by Indication

  • 7.1. Introduction
  • 7.2. Cardiac Arrhythmia
  • 7.3. Coronary Artery Disease
  • 7.4. Heart Failure
  • 7.5. Peripheral Arterial Disease

8. Cardiovascular Devices Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Hospitals
  • 8.4. Specialty Clinics

9. Americas Cardiovascular Devices Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Cardiovascular Devices Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Cardiovascular Devices Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Johnson & Johnson Acquires Shockwave Medical for USD 13.1 Billion, Bolstering Its Cardiovascular Care Offerings
    • 12.3.2. Medtronic and Cardiac Design Labs Unveil Revolutionary External Loop Recorder Technology in India
    • 12.3.3. InfoBionic's MoMe ARC Receives FDA Approval for Revolutionizing Cardiac Monitoring
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. CARDIOVASCULAR DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. CARDIOVASCULAR DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CARDIOVASCULAR DEVICES MARKET DYNAMICS
  • FIGURE 7. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. CARDIOVASCULAR DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. CARDIOVASCULAR DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CARDIOVASCULAR DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY BLOOD PRESSURE MONITORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY BLOOD PRESSURE MONITORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CARDIAC CT & MRI SCANNERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CARDIAC CT & MRI SCANNERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY ELECTROCARDIOGRAM DEVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY ELECTROCARDIOGRAM DEVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HOLTER MONITORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HOLTER MONITORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY REMOTE CARDIAC MONITORING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY REMOTE CARDIAC MONITORING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY STRESS TEST SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY STRESS TEST SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY ARTIFICIAL HEARTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY ARTIFICIAL HEARTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CARDIAC ABLATION CATHETERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CARDIAC ABLATION CATHETERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CORONARY GUIDEWIRES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CORONARY GUIDEWIRES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HEART MONITORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HEART MONITORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HEART VALVES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HEART VALVES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY PACEMAKERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY PACEMAKERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY STENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY STENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CARDIAC ARRHYTHMIA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CARDIAC ARRHYTHMIA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CORONARY ARTERY DISEASE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CORONARY ARTERY DISEASE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HEART FAILURE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 61. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 62. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 63. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 64. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 65. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 66. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 67. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 68. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 69. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 70. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 71. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 72. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 73. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 74. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 75. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 76. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 77. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 78. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 79. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 80. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 81. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 82. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 83. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 84. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 85. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 86. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 87. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 88. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 89. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 90. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 91. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 92. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 93. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 94. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 95. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 96. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 97. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 98. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 99. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 100. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 101. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 102. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 103. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 104. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 105. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 106. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 107. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 108. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 109. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 110. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 111. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 112. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 113. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 114. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 115. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 116. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 117. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 118. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 119. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 120. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 121. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 122. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 123. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 124. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 125. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 126. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 127. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 128. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 141. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 142. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 143. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 144. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 145. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 146. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 147. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 148. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 149. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 150. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 151. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 152. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 153. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 154. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 155. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 156. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 157. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 158. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 159. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 160. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 161. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 162. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 163. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 164. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 165. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 166. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 167. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 168. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 169. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 170. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 171. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 172. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 173. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 174. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 175. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 176. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 177. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 178. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 179. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 180. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 181. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 182. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 183. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 184. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 185. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 186. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 187. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 188. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 189. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 190. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 191. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 192. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 193. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 194. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 195. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 196. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 197. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 198. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 199. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 200. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 201. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 202. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 203. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 204. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 205. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 206. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 207. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 208. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 209. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 210. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 211. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 212. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 213. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 214. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 215. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 216. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 217. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 218. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 219. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 220. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 221. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 222. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 223. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 224. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 225. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 226. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 227. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 228. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 229. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 230. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 231. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 232. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 233. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 234. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 235. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 236. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 237. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 238. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 239. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 240. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 241. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 242. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 243. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 244. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 245. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 246. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 247. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 248. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 249. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 250. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 251. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 252. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 253. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 254. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 255. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 256. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 257. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 258. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 259. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 260. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 273. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 274. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 275. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 276. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 277. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 278. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 279. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 280. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 281. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 282. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 283. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 284. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 285. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 286. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 287. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 288. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 289. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 290. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 291. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 292. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 293. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 294. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 295. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 296. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 297. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 298. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 299. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 300. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 301. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 302. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 303. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 304. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 305. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2023 (USD MILLION)
  • TABLE 306. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2024-2030 (USD MILLION)
  • TABLE 307. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 308. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 309. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 310. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 311. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 312. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 313. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2023 (USD MILLION)
  • TABLE 314. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2024-2030 (USD MILLION)
  • TABLE 315. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGN